Metabolic Signature of Healthy Lifestyle and HCC

NCT03356535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2017-11-29

No results posted yet for this study

Summary

Hepatocellular carcinoma (HCC) is the most common form of liver cancer and its incidence is increasing including in regions where hepatitis infection rates are low. This trend may be the result of increases in 'unhealthy lifestyle' factors. The main aim of this study is to identify metabolic signatures associated with healthy lifestyle behaviours and to relate these signatures to risk of developing HCC to investigate whether the metabolites were of predictive utility for HCC beyond data procured from questionnaires. To address this question, we exploited data from a large European cohort (EPIC) which includes detailed questionnaire-based data as well as metabolomic data.

Conditions

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER
  • Danish Cancer Society

    collaborator OTHER
  • University of Aarhus

    collaborator OTHER
  • Centre for Research in Epidemiology and Population Health (CESP)

    collaborator OTHER
  • Gustave Roussy, Cancer Campus, Grand Paris

    collaborator OTHER
  • German Cancer Research Center

    collaborator OTHER
  • German Institute of Human Nutrition

    collaborator OTHER
  • Hellenic Health Foundation

    collaborator OTHER
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER
  • ISPO Cancer Prevention and Research Institute

    collaborator UNKNOWN
  • Federico II University

    collaborator OTHER
  • HuGeF Foundation

    collaborator UNKNOWN
  • Azienda Sanitaria Provinciale Ragusa

    collaborator OTHER
  • University of Tromso

    collaborator OTHER
  • Institut Català d'Oncologia

    collaborator OTHER
  • Ministry of Health - Government of the Principality of Asturias

    collaborator OTHER_GOV
  • Andalusian School of Public Health

    collaborator OTHER_GOV
  • Universidad de Murcia

    collaborator OTHER
  • Instituto de Salud Pública Gobierno de Navarra

    collaborator UNKNOWN
  • Subdirección de Salud Pública de Gipuzkoa

    collaborator UNKNOWN
  • Skane University Hospital

    collaborator OTHER
  • Umeå University

    collaborator OTHER
  • MORGEN-EPIC, Bilthoven

    collaborator UNKNOWN
  • Prospect-EPIC, Utrecht

    collaborator UNKNOWN
  • University of Oxford

    collaborator OTHER
  • University of Cambridge

    collaborator OTHER
  • International Agency for Research on Cancer

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-01
Primary Completion
2017-09-15
Completion
2017-09-15

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03356535 on ClinicalTrials.gov